Clinical Trials in Strasbourg Cedex, Aslace

Find clinical trials in Strasbourg Cedex, Aslace. Discover local research opportunities and treatment options in your area.

1 Active Trial Found in Strasbourg Cedex

Showing 1 trial on this page

Page 1 of 1

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

NCT ID: NCT05967689

This clinical trial is studying a new drug called zipalertinib for patients with advanced non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGF...

Recruiting

Phase: PHASE2 Conditions: Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations

Search All Trials Browse All Locations